Because of their higher acquisition costs relative to tricyclic antidepressants (TCAs), there has been much debate about whether the use of sertraline or other selective serotonin reuptake inhibitors (SSRls) for
“Long-term outcome and prognosis of obsessive-compulsive disorder with onset in childhood or adolescence,” (in eng) Eur Child Adolesc Psychiatry, 10 (1) (Mar 2001), pp. 37-46 View in ScopusGoogle Scholar [9] D.A. Geller, et al. “Which SSRI? A meta-analysis of pharmacotherapy trials...